<-- test --!> Health and Fitness – Page 634 – Best Reviews By Consumers

Health and Fitness

E. coli outbreak involving daycare centers tops 300 patients; kitchen remains under scrutiny

The patient count in Canada’s daycare center E. Coli outbreak now stands at 310 lab-confirmed cases and public health officials are doubling down on their determination that a central kitchen serving the centers was the source of the pathogen. Only 18 secondary infections — person-to-person infection rather than infection from the original source — have …

E. coli outbreak involving daycare centers tops 300 patients; kitchen remains under scrutiny Read More »

28 tons of food seized in Spain after alleged changing of shelf life dates

Spanish authorities have seized more than 28 tons of food that they said was not suitable for human consumption. Items were found in the facilities of companies in the provinces of Zaragoza, Valencia, and Almería, according to the Guardia Civil. Officials said meat products, frozen fish, and other items were sold with expired shelf life …

28 tons of food seized in Spain after alleged changing of shelf life dates Read More »

Gene Editing: Pairwise and Bayer start new five-year multi-million Dollar collaboration to further advance short-stature corn

Durham, N.C., Monheim, Germany, August 29, 2023 – Pairwise, a food and agriculture company known for bringing the first gene-edited food to the U.S. market, and Bayer today announced a new five-year, multi-million Dollar agreement focused on innovations in short-stature corn. This new program leverages Pairwise’s Fulcrum™ platform and builds on the success of the …

Gene Editing: Pairwise and Bayer start new five-year multi-million Dollar collaboration to further advance short-stature corn Read More »

BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint

Berlin, Germany, Cambridge, MA, USA, August 28, 2023 – Bayer AG and BlueRock Therapeutics LP, a clinical stage cell therapy company and wholly owned independently operated subsidiary of Bayer AG, announced today details of the positive data from the Phase I clinical trial for bemdaneprocel (BRT-DA01), a stem cell derived investigational therapy for treating Parkinson’s …

BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint Read More »